Bedaquiline for the treatment of drug-resistant tuberculosis

Expert Review of Anti-infective Therapy
Sabine BélardMartin P Grobusch

Abstract

Bedaquiline is a much-needed novel drug which is highly effective against drug-resistant tuberculosis. While its clinical development has been laudably fast-tracked and the drug is now available for inclusion into treatment regimens when no suitable alternatives exist, clinical experience with bedaquiline is still limited. Phase III trial data and Phase IV studies are needed particularly to study different patient populations and to optimize treatment regimens. Drug resistance to bedaquiline needs to be monitored carefully, and full access to bedaquiline treatment where it is appropriate and needed must be promoted.

References

Jul 28, 2006·Antimicrobial Agents and Chemotherapy·Stephanie PetrellaWladimir Sougakoff
Dec 21, 2006·Antimicrobial Agents and Chemotherapy·M IbrahimN Veziris
May 15, 2007·Nature Chemical Biology·Anil KoulKoen Andries
Aug 22, 2007·Antimicrobial Agents and Chemotherapy·Emma HuitricSven E Hoffner
Jul 23, 2008·Antimicrobial Agents and Chemotherapy·Nacer LounisKoen Andries
Oct 25, 2008·American Journal of Respiratory and Critical Care Medicine·Nicolas VezirisVincent Jarlier
Dec 17, 2008·Antimicrobial Agents and Chemotherapy·Anna C HaagsmaDirk Bald
Jun 6, 2009·The New England Journal of Medicine·Andreas H DiaconDavid F Mc Neeley
Jul 11, 2009·American Journal of Respiratory and Critical Care Medicine·Murad IbrahimNicolas Veziris
Apr 14, 2010·Antimicrobial Agents and Chemotherapy·Venkata M ReddyCarol A Nacy
May 6, 2010·American Journal of Respiratory and Critical Care Medicine·Armand Van DeunHans L Rieder
Jun 5, 2010·Future Microbiology·Alberto MatteelliAfranio Kritski
Oct 13, 2010·Antimicrobial Agents and Chemotherapy·Shaobin ShangDiane J Ordway
Jun 11, 2011·American Journal of Respiratory and Critical Care Medicine·Tianyu ZhangEric L Nuermberger
Sep 21, 2011·Antimicrobial Agents and Chemotherapy·Rokeya TasneenEric L Nuermberger
Dec 14, 2011·Antimicrobial Agents and Chemotherapy·Marie-Claude RouanKoen Andries
Jan 24, 2012·The European Respiratory Journal·Roland DielTom Schaberg
Apr 4, 2012·Antimicrobial Agents and Chemotherapy·Kathy WilliamsEric L Nuermberger
Apr 13, 2012·The European Respiratory Journal·Giovanni SotgiuGiovanni Battista Migliori
Oct 13, 2012·The European Respiratory Journal·G B MiglioriUNKNOWN “The Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB”
Oct 27, 2012·The European Respiratory Journal·Dennis FalzonUNKNOWN Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB
Dec 6, 2012·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·C R HorsburghUNKNOWN Critical Path to TB Drug Regimens' Access and Appropriate Use Workgroup
Dec 12, 2012·The European Respiratory Journal·Matteo ZignolKatherine Floyd
Mar 5, 2013·The European Respiratory Journal·Francesco BlasiGiovanni Battista Migliori
Aug 31, 2013·The European Respiratory Journal·Clare van HalsemaAlec Bonington
Aug 31, 2013·The European Respiratory Journal·Simon TiberiGiovanni Battista Migliori
Aug 31, 2013·Current Infectious Disease Reports·Navaneetha Pandian Poorana Ganga Devi, Soumya Swaminathan
Sep 28, 2013·The European Respiratory Journal·Lia D'AmbrosioGiovanni Battista Migliori
Nov 1, 2013·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Bonnie ChanJack Brown
Nov 22, 2013·The Annals of Pharmacotherapy·Elias B ChahineHanine Mansour
Feb 25, 2014·Journal of Young Pharmacists : JYP·Mageshwaran Lakshmanan, Alphienes Stanley Xavier
Mar 5, 2014·Antimicrobial Agents and Chemotherapy·Ruben C HartkoornStewart T Cole
Mar 29, 2014·The Lancet Infectious Diseases·Alimuddin I ZumlaAndrew J Nunn
Apr 23, 2014·Current Opinion in Infectious Diseases·H Simon SchaafJames A Seddon
Jun 2, 2014·The European Respiratory Journal·Giovanni SotgiuAndrea Benedetti
Jun 6, 2014·South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde·F ConradieN Ndjeka

❮ Previous
Next ❯

Citations

Oct 20, 2015·Expert Opinion on Pharmacotherapy·Emanuele PontaliGiovanni Battista Migliori
Jan 23, 2016·Der Internist·M P GrobuschS Bélard
Nov 1, 2016·The Journal of Antimicrobial Chemotherapy·Moloko C CholoRonald Anderson
Nov 18, 2016·American Journal of Respiratory and Critical Care Medicine·Elizabeth P HarauszUNKNOWN Sentinel Project on Pediatric Drug-Resistant Tuberculosis
May 7, 2019·Journal of Chemotherapy·Tommaso MatucciElena Chiappini

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

JAMA : the Journal of the American Medical Association
A Ponce de LeonJ Sifuentes-Osornio
The Lancet Infectious Diseases
Kanchan AjbaniCamilla Rodrigues
The Lancet Infectious Diseases
Gyanshankar P Mishra
© 2021 Meta ULC. All rights reserved